Top Industry Leaders in the Q Fever Market
Latest Q fever Companies Updates:
Pfizer Inc.'s acquisition of Global Blood Therapeutics, known for its Voxelotor drug for sickle cell disease, could potentially influence future antibiotics development due to shared research and development resources.
Melinta Therapeutics, Inc.'s acquisition by ANI Pharmaceuticals, Inc. adds Orbactiv (oritavancin) to ANI's antibiotic portfolio, which could indirectly impact availability and access to Q Fever treatment options..
List of Q fever Key companies in the market:
- Merck KGaA (Germany)
- Teva Pharmaceutical (Israel)
- Pfizer Inc. (US)
- Basilea Pharmaceutica Ltd (Switzerland)
- Sanofi S.A.(France)
- Melinta Therapeutics, Inc. (US)
- Bayer AG (Germany)
- Johnson & Johnson Services, Inc. (US)
- Yashica Pharmaceuticals (India)
- AtoxBio (US)